ScreenerHero

PXMDPaxMedica Inc. Common Stock

NAS · US · Healthcare · Biotechnology · paxmedica.com
0.0008USD+14.29%Mkt Cap: 101011 $P/E: 0.00

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap101.01K $
Enterprise Value-343.84K $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.29M $
Revenue/Share—
Last Price0.0008 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)2.44
EPS (Forward)-1.09
52W Range
0.00014% of range0.0200
52W High0.0200 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-540.31%
ROA-321.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.77M $
CapEx (TTM)—
FCF Margin—
FCF Yield-2990.77%
Net Debt-444.86K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.36
Quick Ratio0.20
Book Value/Sh-0.1780 USD
Cash/Share0.0040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:17
Split DateOct 31, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.126.26M
Float—
Insiders0.00%
Institutions0.15%
Short Interest
Short Ratio0.1d
Short % Float8.62%
Short % Out.8.54%
Shares Short637.72K
Short (prev mo.)552.33K
Technical
SMA 500.0006 (+43.9%)
SMA 2000.0004 (+87.6%)
Beta-32.35
S&P 52W Chg18.16%
Avg Vol (30d)1.47K
Avg Vol (10d)3.66K
Technical Indicators
RSI (14)68.9
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0008 USD
BB Middle0.0006 USD
BB Lower0.0004 USD
BB Width73.63%
ATR (14)0.0001 USD
Vol Ratio (20d)0.11x